Olympiad Research’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29,771
Closed -$1.01M 331
2021
Q2
$1.01M Buy
+29,771
New +$759K 0.35% 96

Olympiad Research's CNST Position: Q3 2021 in Review

Olympiad Research sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 29,771 shares — an estimated $1.01M sold.

Olympiad Research first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.01M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Olympiad Research reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Olympiad Research sold 29,771 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.01M.
  • Olympiad Research first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Olympiad Research's Constellation Pharmaceuticals, Inc. position peaked at $1.01M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Olympiad Research's 13F filing for Q3 2021, filed 9 Nov 2021.